초록 ▼

Compounds and compositions for eliciting or enhancing immune reactivity to HER-2/neu protein are disclosed. The compounds include polypeptides and nucleic acid molecules encoding such peptides. The compounds may be used for the prevention or treatment of malignancies in which the HER-2/neu oncogene

Compounds and compositions for eliciting or enhancing immune reactivity to HER-2/neu protein are disclosed. The compounds include polypeptides and nucleic acid molecules encoding such peptides. The compounds may be used for the prevention or treatment of malignancies in which the HER-2/neu oncogene is associated.

대표청구항 ▼

1. A method for eliciting or enhancing an immune response to HER-2/neu protein, comprising transfecting antigen presenting cells of a warm-blooded animal ex vivo with a nucleic acid molecule and subsequently delivering the transfected cells to the animal in an amount effective to elicit or enhance s

1. A method for eliciting or enhancing an immune response to HER-2/neu protein, comprising transfecting antigen presenting cells of a warm-blooded animal ex vivo with a nucleic acid molecule and subsequently delivering the transfected cells to the animal in an amount effective to elicit or enhance said response, wherein the nucleic acid molecule directs the expression of a polypeptide encoded by a DNA sequence selected from:(a) nucleotides 2026 through 3765 of SEQ ID NO:1, and (b) DNA sequences that hybridize to a nucleotide sequence complementary to nucleotides 2026 through 3765 of SEQ ID NO:1 under moderately stringent conditions, wherein the DNA sequence encodes a polypeptide that produces an immune response to HER-2/neu protein, and wherein the hybridization conditions comprise prewashing in a solution of 5×SSC, 0.5% SDS, 1.0 mM EDTA (pH 8.0); hybridization at 50° to 65° C. in 5×SSC overnight, followed by washing twice at 65° C. for 20 minutes with each of 2×, 0.5× and 0.2×SSC containing 0.1% SDS, with the proviso that the polypeptide of (b) is not intact HER-2/neu protein. 2. A method for eliciting or enhancing an immune response to HER-2/neu protein, comprising infecting antigen presenting cells of a warm-blooded animal ex vivo with a viral vector and subsequently delivering the infected cells to the animal in an amount effective to elicit or enhance said response, wherein the viral vector directs the expression of a polypeptide encoded by a DNA sequence selected from:(a) nucleotides 2026 through 3765 of SEQ ID NO:1, and (b) DNA sequences that hybridize to a nucleotide sequence complementary to nucleotides 2026 through 3765 of SEQ ID NO:1 under moderately stringent conditions, wherein the DNA sequence encodes a polypeptide that produces an immune response to HER-2/neu protein, and wherein the hybridization conditions comprise prewashing in a solution of 5×SSC, 0.5% SDS, 1.0 mM EDTA (pH 8.0), hybridization at 50° to 65° C. in 5×SSC overnight; followed by washing twice at 65° C. for 20 minutes with each of 2×, 0.5× and 0.2×SSC containing 0.1% SDS, with the proviso that the polypeptide of (b) is not intact HER-2/neu protein. 3. The method of claims 1 or 2 wherein the polypeptide has the amino acid sequence of SEQ ID NO:2 from amino acid 676 through amino acid 1255.